Legal & General Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.95B | Buy |
5,379,364
+85,723
| +2% | +$86.9M | 1.14% | 12 |
|
|
2025
Q4 | $5.69B | Sell |
5,293,641
-90,358
| -2% | -$86.4M | 1.26% | 11 |
|
|
2025
Q3 | $4.11B | Buy |
5,383,999
+154,714
| +3% | +$115M | 0.92% | 12 |
|
|
2025
Q2 | $4.08B | Sell |
5,229,285
-276,263
| -5% | -$215M | 1.01% | 12 |
|
|
2025
Q1 | $4.55B | Sell |
5,505,548
-79,497
| -1% | -$66.1M | 1.24% | 11 |
|
|
2024
Q4 | $4.31B | Sell |
5,585,045
-78,599
| -1% | -$65.1M | 1.14% | 11 |
|
|
2024
Q3 | $5.02B | Sell |
5,663,644
-27,904
| -0.5% | -$25.1M | 1.32% | 9 |
|
|
2024
Q2 | $5.15B | Sell |
5,691,548
-197,059
| -3% | -$158M | 1.46% | 8 |
|
|
2024
Q1 | $4.58B | Sell |
5,888,607
-19,341
| -0.3% | -$13.8M | 1.32% | 8 |
|
|
2023
Q4 | $3.44B | Sell |
5,907,948
-16,857
| -0.3% | -$9.84M | 1.07% | 11 |
|
|
2023
Q3 | $3.18B | Sell |
5,924,805
-182,455
| -3% | -$94M | 1.11% | 10 |
|
|
2023
Q2 | $2.86B | Buy |
6,107,260
+196,292
| +3% | +$82.3M | 0.93% | 12 |
|
|
2023
Q1 | $2.03B | Buy |
5,910,968
+110,469
| +2% | +$37.3M | 0.73% | 19 |
|
|
2022
Q4 | $2.12B | Sell |
5,800,499
-132,605
| -2% | -$47M | 0.81% | 17 |
|
|
2022
Q3 | $1.92B | Sell |
5,933,104
-307,204
| -5% | -$97.3M | 0.75% | 17 |
|
|
2022
Q2 | $2.02B | Sell |
6,240,308
-56,000
| -0.9% | -$16.8M | 0.72% | 19 |
|
|
2022
Q1 | $1.8B | Buy |
6,296,308
+351,755
| +6% | +$90.5M | 0.55% | 24 |
|
|
2021
Q4 | $1.64B | Sell |
5,944,553
-65,852
| -1% | -$16.7M | 0.5% | 28 |
|
|
2021
Q3 | $1.39B | Buy |
6,010,405
+139,476
| +2% | +$34.4M | 0.45% | 35 |
|
|
2021
Q2 | $1.35B | Buy |
5,870,929
+231,301
| +4% | +$46.5M | 0.45% | 35 |
|
|
2021
Q1 | $1.05B | Sell |
5,639,628
-123,203
| -2% | -$24.1M | 0.39% | 46 |
|
|
2020
Q4 | $973M | Buy |
5,762,831
+69,686
| +1% | +$10.4M | 0.38% | 49 |
|
|
2020
Q3 | $843M | Sell |
5,693,145
-126,174
| -2% | -$19.5M | 0.38% | 53 |
|
|
2020
Q2 | $955M | Sell |
5,819,319
-15,926
| -0.3% | -$2.44M | 0.46% | 39 |
|
|
2020
Q1 | $809M | Buy |
5,835,245
+180,486
| +3% | +$24.8M | 0.47% | 40 |
|
|
2019
Q4 | $743M | Buy |
5,654,759
+82,593
| +1% | +$9.57M | 0.35% | 54 |
|
|
2019
Q3 | $623M | Buy |
5,572,166
+21,718
| +0.4% | +$2.42M | 0.33% | 56 |
|
|
2019
Q2 | $615M | Sell |
5,550,448
-69,532
| -1% | -$8.19M | 0.33% | 57 |
|
|
2019
Q1 | $729M | Buy |
5,619,980
+671,128
| +14% | +$81.6M | 0.42% | 43 |
|
|
2018
Q4 | $573M | Buy |
4,948,852
+237,632
| +5% | +$26.5M | 0.44% | 39 |
|
|
2018
Q3 | $506M | Buy |
4,711,220
+31,617
| +0.7% | +$3.16M | 0.36% | 51 |
|
|
2018
Q2 | $399M | Sell |
4,679,603
-36,105
| -0.8% | -$2.97M | 0.31% | 65 |
|
|
2018
Q1 | $365M | Sell |
4,715,708
-278,553
| -6% | -$22.4M | 0.28% | 77 |
|
|
2017
Q4 | $422M | Sell |
4,994,261
-200,568
| -4% | -$17.1M | 0.31% | 66 |
|
|
2017
Q3 | $444M | Buy |
5,194,829
+93,633
| +2% | +$7.68M | 0.33% | 59 |
|
|
2017
Q2 | $420M | Buy |
5,101,196
+136,660
| +3% | +$11.1M | 0.34% | 57 |
|
|
2017
Q1 | $418M | Buy |
4,964,536
+192,727
| +4% | +$15.4M | 0.35% | 53 |
|
|
2016
Q4 | $351M | Buy |
4,771,809
+33,877
| +0.7% | +$2.52M | 0.33% | 64 |
|
|
2016
Q3 | $380M | Buy |
4,737,932
+33,625
| +0.7% | +$2.69M | 0.39% | 51 |
|
|
2016
Q2 | $370M | Sell |
4,704,307
-55,363
| -1% | -$4.17M | 0.39% | 51 |
|
|
2016
Q1 | $343M | Sell |
4,759,670
-58,524
| -1% | -$4.43M | 0.38% | 53 |
|
|
2015
Q4 | $406M | Buy |
4,818,194
+135,075
| +3% | +$11.2M | 0.46% | 41 |
|
|
2015
Q3 | $392M | Buy |
4,683,119
+135,096
| +3% | +$11.4M | 0.48% | 40 |
|
|
2015
Q2 | $380M | Buy |
4,548,023
+64,275
| +1% | +$4.9M | 0.45% | 44 |
|
|
2015
Q1 | $326M | Sell |
4,483,748
-5,749
| -0.1% | -$409K | 0.39% | 53 |
|
|
2014
Q4 | $310M | Sell |
4,489,497
-95,012
| -2% | -$6.41M | 0.36% | 61 |
|
|
2014
Q3 | $297M | Sell |
4,584,509
-103,662
| -2% | -$6.56M | 0.36% | 59 |
|
|
2014
Q2 | $291M | Buy |
4,688,171
+108,020
| +2% | +$6.44M | 0.34% | 64 |
|
|
2014
Q1 | $270M | Sell |
4,580,151
-86,234
| -2% | -$4.81M | 0.33% | 69 |
|
|
2013
Q4 | $238M | Buy |
4,666,385
+34,853
| +0.8% | +$1.75M | 0.29% | 80 |
|
|
2013
Q3 | $233M | Sell |
4,631,532
-18,479
| -0.4% | -$967K | 0.31% | 76 |
|
|
2013
Q2 | $228M | Buy |
+4,650,011
| New | +$253M | 0.32% | 70 |
|
Other funds holding LLY
VCM
VPM
Legal & General Group's LLY Position: Q1 2026 in Review
Legal & General Group increased its Eli Lilly (LLY) stake by 1.6% in Q1 2026, buying an estimated $86.9M and bringing the position to 5,379,364 shares worth $4.95B. The position accounts for 1.14% of the portfolio, ranked #12.
Legal & General Group first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.69B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Legal & General Group held 5,379,364 shares of Eli Lilly worth $4.95B as of Q1 2026.
- Legal & General Group bought 85,723 Eli Lilly shares in Q1 2026, an estimated $86.9M.
- Eli Lilly made up 1.14% of Legal & General Group's portfolio in Q1 2026, its #12 holding.
- Legal & General Group first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Legal & General Group's Eli Lilly position peaked at $5.69B in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.